| AGM, EGM Calendar |
| Wednesday, May 18 |
| UBM |
| Jupiter Fund Management |
| Antofagasta |
| Paddy Power Betfair |
| Circassia Pharmaceuticals |
| ProPhotonix |
| STM Group |
| Satellite Solutions Worldwide |
| CPPGroup |
| Vitec Group |
| Safecharge International |
| European REIT |
| Panmure Gordon & Co |
| Marshalls |
| Circle Holdings |
| Bankers Petroleum |
| Frenkel Topping Group |
| Johnston Press |
| Stilo International |
| Foxtons Group |
| Xaar |
| Rathbone Brothers |
| Skyepharma |
| Chesnara |
| Playtech |
| Zotefoams |
| Thursday, May 19 |
| Next |
| Merlin Entertainments |
| Informa |
| Balfour Beatty |
| Prudential |
| StatPro Group |
| Computacenter |
| PPHE Hotel Group |
| ProPhotonix |
| Sherborne Investors |
| Cineworld Group |
| Learning Technologies |
| Revolymer |
| Crossrider |
| Science Group |
| Safestyle UK |
| GLI Finance |
| Staffline Group |
| Riverstone Energy |
| Gamma Communications |
| Glencore |
| Petrofac |
| HaloSource (re recreational water business sale) |
| Ferrexpo |
| North Midland Construction |
| Portmeiron Group |
| Concurrent Technology |
| Game Digital (re loan facility with Lajedosa Investments) |
| Conviviality (re acquisition of Bibendum PLB & proposed placing) |
| Exova Group |
| LMS Capital |
| PV Crystalox Solar |
| Hiscox |
| Friday, May 20 |
| Spectris |
| Moss Bros Group |
| Applegreen |
| Richland Resources |
| Snacktime |
| Hydrogen Group |
| John Menzies |
| Hochschild Mining |
| Vislink |
| Headlam Group |
| Baillie Gifford Shin Nippon |
| Spectris |
| Monday, May 23 |
| Restore |
| Stock Spirits Group |
| Noricum Gold |
| Nasstar |
| 4D Pharma |
| Hvivo |
| Plant Healthcare |
| Synety Group |
| Vertu Capital |
| Tuesday, May 24 |
| Marshall Motor Holdings |
| Royal Dutch Shell |
| Metro Bank |
| Card Factory |
| Ranger Direct Lending |
| Accesso Technology Group |
| Epwin Group |
| Belgravium Technologies |
| GVC Holdings |
| Merchants Trust |
| Keller Group |
| Telit Communications |
| Quarto Group |
| Copyright 2016 Alliance News Limited. All Rights Reserved. |
24 May 2021 09:42
More positive data reported from 4D Pharma trial of 'Blautix'
(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced additional positive data from its completed phase 2 trial of 'LBP Blautix' on Monday, in subjects with irritable bowel syndrome with constipation (IBS-C) or with diarrhea (IBS-D).
Read more